Ukraine: A case study. Making HIV and viral hepatitis treatments accessible

Ukraine has the second largest HIV epidemic in Eastern Europe and Central Asia. And nearly 1.5 million people in the country are living with hepatitis C.

How do you get affordable quality medicines to these people in need?

This January, MPP visited Ukraine to engage with partners – from patients to medical experts, from originators to generic manufacturers, from civil society to the WHO and many more. Unleashing the power of partnership, MPP’s licences have led to the supply of over 20,000 courses of hepatitis C treatments and 1.5 million packs of DTG and combination products for HIV treatment in Ukraine.

➡️Visit our online channel: https://medicinespatentpool.org/stories/

Twitter: https://twitter.com/MedsPatentPool
LinkedIn: https://www.linkedin.com/company/medicines-patent-pool/

Contact: press@medicinespatentpool.org

About the Medicines Patent Pool:
The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations. To date, MPP has signed agreements with ten patent holders for thirteen HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals and a tuberculosis treatment. MPP was founded by Unitaid which serves as sole funder for MPP’s activities in HIV, hepatitis C and tuberculosis.

Видео Ukraine: A case study. Making HIV and viral hepatitis treatments accessible канала MedicinesPatentPool